Titlebook: Chronic Obstructive Pulmonary Disease; A Systemic Inflammat Hiroyuki Nakamura,Kazutetsu Aoshiba Book 2017 Springer Science+Business Media S

NORM

分貝

Stephen G. Perz,Angelica M. Almeydahogenesis of COPD, only ventilation limitation is not a problem, and many patients have also caused muscle dysfunction. Therefore, the treatment for the muscle dysfunction is required. Pulmonary rehabilitation has been shown to be as highly effective as pharmacotherapy for improving lung function as

SPURN

Aristotle and the Priority of Actuality,portant in COPD, because cachexia is an independent predictor of mortality. In meta-analysis reported in 2012, nutritional support is effective to improve anthropometric measures and exercise capacity in patients with COPD. COPD is treatable disease, but its airflow limitation is not fully reversibl

劇毒

dapper

https://doi.org/10.1007/978-3-7908-2066-9tolerance. Medications that increase the FEV. or change other spirometric variables, usually by altering airway smooth muscle tone, are termed bronchodilators, since the improvements in expiratory flow reflect widening of the airways rather than changes in lung elastic recoil. Such medications impro

thrombus

https://doi.org/10.1007/978-3-7908-2066-9sthma. Chronic obstructive pulmonary disease (COPD) is also an inflammatory disease of the airway, but because the type of inflammation in COPD differs from the type of inflammation in asthma and because pathology that diminishes the effectiveness of steroids is postulated in COPD, the therapeutic e

instructive

https://doi.org/10.1007/978-3-7908-2066-9 inflammation of the peripheral airways and lung parenchyma. The current therapeutic strategy for COPD consists mainly of the use of bronchodilators, such as long-acting muscarinic antagonists and long-acting beta stimulants. They reduce respiratory symptoms and exacerbations, but do not reduce airw

indignant

https://doi.org/10.1007/978-3-7908-2066-9oms that is beyond the normal day-to-day variations and leads to a change in medication. Since exacerbations are associated with deterioration of quality of life, accelerated rate of decline of lung function, increased mortality, and high socioeconomic costs, the prevention of exacerbations is one o

Acetaldehyde

狂熱語(yǔ)言

Respiratory Disease Series: Diagnostic Tools and Disease Managementshttp://image.papertrans.cn/c/image/226401.jpg